glp-1 and gip receptor agonist Dual GIP/GLP-1 agonists: New advances for treating type-2 diabetes GIP Receptor Agonism Attenuates GLP-1
Description
Naturally occurring mutations in G protein-coupled receptors associated with obesity and type 2 diabetes mellitus
Nat Rev Dis Primers (2016) 2:16057
These views are not necessarily endorsed or verified by the National Academy of Medicine or the National Academies of Sciences, Engineering, and Medicine and should not be construed as reflecting any group consensus
This enhancement is demonstrable through an increase in mitochondrial DNA content, the upregulation of genes integral to mitochondrial biogenesis, and the increased expression of proteins pivotal in oxidative phosphorylation
